10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -35.32% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 58.68% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 50.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.05% |
| Mar 31, 2026 | -47.37% |
| Dec 31, 2025 | 69.30% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | 36.30% |
| Mar 31, 2025 | 28.45% |
| Dec 31, 2024 | -60.95% |
| Sep 30, 2024 | 34.94% |
| Jun 30, 2024 | 71.77% |
| Mar 31, 2024 | 57.46% |
| Dec 31, 2023 | 32.14% |
| Sep 30, 2023 | -26.77% |
| Jun 30, 2023 | 31.94% |
| Mar 31, 2023 | 65.43% |
| Dec 31, 2022 | -144.54% |
| Sep 30, 2022 | -27.98% |
| Jun 30, 2022 | -56.64% |
| Mar 31, 2022 | -582.37% |
| Dec 31, 2021 | 10.40% |